Skip to main content
Top Left Menu
  • Careers
  • Media
  • Investors
What are you looking for?
Galderma Logo
Top Right Menu

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • United Kingdom
  • United States
  • Contact us
  • Search

Investors

  • Overview
    • Overview
    • Dermatology category leader
    • IPO
  • Key releases
  • Events & presentations
  • Financial reports
  • Share information
    • Share price
    • Share details
    • Dividend information
    • Analyst coverage
    • Consensus
  • Corporate governance
    • Governance
    • Executive Committee
    • ESG Index
  • Contacts & alerts
    • Email alerts
    • Investor Relations team

Key releases

Key releases are ad hoc announcements pursuant to SIX Swiss Exchange Art. 53 LR

April 24, 2024
Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth
March 26, 2024
Galderma Announces Full Exercise of Over-Allotment Option

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
Displaying 21 - 22 of 22

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Footer Social Links InstagramLinkedInTwitter
© Galderma 2026
Footer Links
  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Nestle Skin Health global site. Are you sure you want to leave this page?

Yes, thanks Go back